Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children.
Green
M
M
Department of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh Transplantation Institute, Pennsylvania, USA.
Reyes
J
J
Jabbour
N
N
Yunis
E
E
Putnam
P
P
Todo
S
S
Rowe
D
D
D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D004279:DNA, Viral / Q000097:blood; D015774:Ganciclovir / Q000627:therapeutic use; D006683:HLA-DQ Antigens / Q000235:genetics; D059848:HLA-DQ alpha-Chains; D006566:Herpesviridae Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000517:prevention & control; D004854:Herpesvirus 4, Human / Q000302:isolation & purification*; D006801:Humans; D007422:Intestines / Q000637:transplantation*; D008214:Lymphocytes / Q000821:virology; D008232:Lymphoproliferative Disorders / Q000175:diagnosis*; D016133:Polymerase Chain Reaction / Q000379:methods*; D011183:Postoperative Complications; D014184:Transplantation, Homologous / Q000276:immunology
D000998:Antiviral Agents; D004279:DNA, Viral; D006683:HLA-DQ Antigens; D059848:HLA-DQ alpha-Chains; C069050:HLA-DQA1 antigen; D015774:Ganciclovir